Advance Multicenter Clinical Trial: MRD-Driven Therapy in Newly Diagnosed Multiple Myeloma Patients

被引：0
|
作者：
Landgren, Ola [1 ]
Kazandjian, Dickran [2 ]
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-202079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7035 / 7036
页数：2
相关论文
共 50 条
  • [31] Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
    Palumbo, Antonio
    Gay, Francesca
    Cavallo, Federica
    Di Raimondo, Francesco
    Larocca, Alessandra
    Hardan, Izhar
    Nagler, Arnon
    Petrucci, Maria T.
    Hajek, Roman
    Pezzatti, Sara
    Delforge, Michel
    Patriarca, Francesca
    Donato, Francesca
    Cerrato, Chiara
    Nozzoli, Chiara
    Yu, Zhinuan
    Boccadifuoco, Luana
    Caravita, Tommaso
    Benevolo, Giulia
    Guglielmelli, Tommasina
    Vincelli, Donatella
    Jacques, Christian
    Dimopoulos, Meletios A.
    Ciccone, Giovannino
    Musto, Pellegrino
    Corradini, Paolo
    Cavo, Michele
    Boccadoro, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (30) : 3459 - +
  • [32] Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
    Ria, Roberto
    Reale, Antonia
    Solimando, Antonio Giovanni
    Mangialardi, Giuseppe
    Moschetta, Michele
    Gelao, Lucia
    Iodice, Giuseppe
    Vacca, Angelo
    STEM CELLS INTERNATIONAL, 2012, 2012
  • [33] Hemostasis in Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy
    Urnova, Evdokia S.
    Mendeleeva, Larisa P.
    Pokrovskaya, Olga S.
    Gracheva, Marina A.
    Gemdzhian, Eduard G.
    Kuzmina, Larisa A.
    Tarandovsky, Ivan D.
    Firsova, Maiia V.
    Nareiko, Mariya V.
    Seregina, Elena A.
    Balandina, Anna N.
    Ataullakhanov, Fazoil I.
    Vasil'ev, Sergei A.
    Savchenko, Valeri G.
    BLOOD, 2015, 126 (23)
  • [34] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    BLOOD, 2010, 116 (05) : 679 - 686
  • [35] Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    FUTURE ONCOLOGY, 2015, 11 (11) : 1643 - 1658
  • [36] Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Kunisada, Kodai
    Nomura-Yogo, Moe
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 91 - 95
  • [37] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 690 - 691
  • [38] Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma
    Moreau, Philippe
    Giralt, Sergio A.
    LEUKEMIA RESEARCH, 2012, 36 : S13 - S18
  • [39] Analysis of compression fractures in patients with newly diagnosed multiple myeloma on comprehensive therapy
    Angtuaco, EJ
    Justus, M
    Sethi, R
    Erdem, E
    Van Hemert, RL
    Stringer, WA
    RADIOLOGY, 2001, 221 : 138 - 138
  • [40] Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma
    Meletios A Dimopoulos
    Efstathios Kastritis
    Nature Clinical Practice Oncology, 2008, 5 : 690 - 691
12345